242 related articles for article (PubMed ID: 1418007)
1. Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations.
Oddis CV; Okano Y; Rudert WA; Trucco M; Duquesnoy RJ; Medsger TA
Arthritis Rheum; 1992 Oct; 35(10):1211-7. PubMed ID: 1418007
[TBL] [Abstract][Full Text] [Related]
2. The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-Scl.
Marguerie C; Bunn CC; Copier J; Bernstein RM; Gilroy JM; Black CM; So AK; Walport MJ
Medicine (Baltimore); 1992 Nov; 71(6):327-36. PubMed ID: 1435228
[TBL] [Abstract][Full Text] [Related]
3. Anti-PM-Scl antibody in patients with systemic sclerosis.
Koschik RW; Fertig N; Lucas MR; Domsic RT; Medsger TA
Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S12-6. PubMed ID: 22261302
[TBL] [Abstract][Full Text] [Related]
4. The human exosome: an autoantigenic complex of exoribonucleases in myositis and scleroderma.
Brouwer R; Pruijn GJ; van Venrooij WJ
Arthritis Res; 2001; 3(2):102-6. PubMed ID: 11178117
[TBL] [Abstract][Full Text] [Related]
5. Novel aspects of autoantibodies to the PM/Scl complex: clinical, genetic and diagnostic insights.
Mahler M; Raijmakers R
Autoimmun Rev; 2007 Aug; 6(7):432-7. PubMed ID: 17643929
[TBL] [Abstract][Full Text] [Related]
6. Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies.
Hausmanowa-Petrusewicz I; Kowalska-Oledzka E; Miller FW; Jarzabek-Chorzelska M; Targoff IN; Blaszczyk-Kostanecka M; Jablonska S
Arthritis Rheum; 1997 Jul; 40(7):1257-66. PubMed ID: 9214426
[TBL] [Abstract][Full Text] [Related]
7. Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients.
Hanke K; Brückner CS; Dähnrich C; Huscher D; Komorowski L; Meyer W; Janssen A; Backhaus M; Becker M; Kill A; Egerer K; Burmester GR; Hiepe F; Schlumberger W; Riemekasten G
Arthritis Res Ther; 2009; 11(1):R22. PubMed ID: 19220911
[TBL] [Abstract][Full Text] [Related]
8. C1D is a major autoantibody target in patients with the polymyositis-scleroderma overlap syndrome.
Schilders G; Egberts WV; Raijmakers R; Pruijn GJ
Arthritis Rheum; 2007 Jul; 56(7):2449-54. PubMed ID: 17599775
[TBL] [Abstract][Full Text] [Related]
9. Immunolocalization and partial characterization of a nucleolar autoantigen (PM-Scl) associated with polymyositis/scleroderma overlap syndromes.
Reimer G; Scheer U; Peters JM; Tan EM
J Immunol; 1986 Dec; 137(12):3802-8. PubMed ID: 3537125
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies to nucleolar antigens in systemic scleroderma: clinical correlations.
Błaszczyk M; Jarzabek-Chorzelska M; Jabłońska S; Chorzelski T; Kołacińska-Strasz Z; Beutner EH; Kumar V
Br J Dermatol; 1990 Oct; 123(4):421-30. PubMed ID: 2128868
[TBL] [Abstract][Full Text] [Related]
11. The changing landscape of the clinical value of the PM/Scl autoantibody system.
Mahler M; Fritzler MJ
Arthritis Res Ther; 2009; 11(2):106. PubMed ID: 19351430
[TBL] [Abstract][Full Text] [Related]
12. [PM-Scl antibody positive systemic sclerosis associated with inclusion-body myositis].
Kim S; Genth E; Krieg T; Hunzelmann N
Z Rheumatol; 2005 Oct; 64(7):499-502. PubMed ID: 16244833
[TBL] [Abstract][Full Text] [Related]
13. Clinical and serologic correlates of anti-PM/Scl antibodies in systemic sclerosis: a multicenter study of 763 patients.
D'Aoust J; Hudson M; Tatibouet S; Wick J; ; Mahler M; Baron M; Fritzler MJ
Arthritis Rheumatol; 2014 Jun; 66(6):1608-15. PubMed ID: 24577935
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies directed to novel components of the PM/Scl complex, the human exosome.
Brouwer R; Vree Egberts WT; Hengstman GJ; Raijmakers R; van Engelen BG; Seelig HP; Renz M; Mierau R; Genth E; Pruijn GJ; van Venrooij WJ
Arthritis Res; 2002; 4(2):134-8. PubMed ID: 11879549
[TBL] [Abstract][Full Text] [Related]
15. The clinical phenotype of systemic sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort.
Lazzaroni MG; Marasco E; Campochiaro C; DeVries-Bouwstra J; Gonzalez-Perez MI; Rojas-Serrano J; Hachulla E; Zanatta E; Barsotti S; Furini F; Triantafyllias K; Abignano G; Truchetet ME; De Luca G; De Langhe E; Hesselstrand R; Ingegnoli F; Bertoldo E; Smith V; Bellando-Randone S; Poormoghim H; Colombo E; Ceribelli A; Furloni A; Zingarelli S; Cavazzana I; Franceschini F; Del Galdo F; Denton CP; Cavagna L; Distler O; Allanore Y; Airò P;
Rheumatology (Oxford); 2021 Nov; 60(11):5028-5041. PubMed ID: 33580257
[TBL] [Abstract][Full Text] [Related]
16. Studies of HLA-DR and DQ alleles in systemic sclerosis patients with autoantibodies to RNA polymerases and U3-RNP (fibrillarin).
Falkner D; Wilson J; Fertig N; Clawson K; Medsger TA; Morel PA
J Rheumatol; 2000 May; 27(5):1196-202. PubMed ID: 10813287
[TBL] [Abstract][Full Text] [Related]
17. Identification of protein components reactive with anti-PM/Scl autoantibodies.
Gelpi C; Algueró A; Angeles Martinez M; Vidal S; Juarez C; Rodriguez-Sanchez JL
Clin Exp Immunol; 1990 Jul; 81(1):59-64. PubMed ID: 2199097
[TBL] [Abstract][Full Text] [Related]
18. Segregation of autoantibodies with disease in monozygotic twin pairs discordant for systemic sclerosis. Three further cases.
McHugh NJ; Harvey GR; Whyte J; Dorsey JK
Arthritis Rheum; 1995 Dec; 38(12):1845-50. PubMed ID: 8849358
[TBL] [Abstract][Full Text] [Related]
19. PM-Scl-75 is the main autoantigen in patients with the polymyositis/scleroderma overlap syndrome.
Raijmakers R; Renz M; Wiemann C; Egberts WV; Seelig HP; van Venrooij WJ; Pruijn GJ
Arthritis Rheum; 2004 Feb; 50(2):565-9. PubMed ID: 14872500
[TBL] [Abstract][Full Text] [Related]
20. PM1-Alpha ELISA: the assay of choice for the detection of anti-PM/Scl autoantibodies?
Mahler M; Fritzler MJ
Autoimmun Rev; 2009 Mar; 8(5):373-8. PubMed ID: 19103309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]